PW MEDTECH (01358) issued a profit warning, expecting the shareholders' attributable profit to amount to 83 million to 102 million yuan by 2025.
PwC and Shun (01358) announced that the Group is expected to achieve a net profit between RMB 120 million and RMB 147 million for the year ending December 31, 2025, a decrease of 38% to 24% compared to approximately RMB 193 million for the year ending December 31, 2024; and a net profit attributable to owners of the company between RMB 83 million and RMB 102 million for the year ending December 31, 2025, a decrease of 45% to 32% compared to approximately RMB 151 million for the year ending December 31, 2024.
PW MEDTECH (01358) announced that it is expected to achieve a net profit ranging from RMB 120 million to RMB 147 million for the year ending December 31, 2025, a decrease of 38% to 24% compared to approximately RMB 193 million for the year ending December 31, 2024. The Company also expects to achieve a net profit attributable to owners of the Company ranging from RMB 83 million to RMB 102 million for the year ending December 31, 2025, a decrease of 45% to 32% compared to approximately RMB 151 million for the year ending December 31, 2024.
The decrease mentioned above is mainly due to the decrease in sales of the infusion device business segment as a result of the comprehensive implementation of centralized procurement.
Related Articles
ASIA CEMENT CH(00743) will distribute a final dividend of 0.03 yuan per share on July 10th.
HP LIVING TECH (01682) plans to carry out a 1-for-1 rights issue, aiming to raise a net amount of up to HK$64.9 million.
Shenzhen Zhaowei Machinery & Electronics (02692) H shares added to the list of securities eligible for trading under the Hong Kong Stock Connect.
ASIA CEMENT CH(00743) will distribute a final dividend of 0.03 yuan per share on July 10th.
HP LIVING TECH (01682) plans to carry out a 1-for-1 rights issue, aiming to raise a net amount of up to HK$64.9 million.
Shenzhen Zhaowei Machinery & Electronics (02692) H shares added to the list of securities eligible for trading under the Hong Kong Stock Connect.
RECOMMEND
